Leerink raises Neurogene stock price target to $77 on Rett data
Leerink raises Neurogene stock price target to $77 on Rett data
Leerink raises Neurogene stock price target to $77 on Rett data
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.